ZyVersa Therapeutics shares are trading higher Monday after the company announced the publication of a scientific paper in a peer-reviewed journal that reinforces the rationale for inhibiting ASC with IC 100 to potentially attenuate cardiac comorbidities in patients with Alzheimer's Disease.
SoFi is set to report its first-quarter financial results before the market open on Monday, April 29 and will host a conference call at 8:00 a.m. ET the same day. According to estimates from Benzinga Pro, analysts expect the company to report earnings of 1 cent per share and quarterly revenue of $555.997 million.